Loading…
Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy
Abstract The aim of this study was to assess the impact of radiotherapy on serum vascular endothelial growth factor (VEGF) levels in patients with pharyngeal and laryngeal cancer. Serum VEGF concentrations were determined in 37 patients before, during, and after radiotherapy by using a quantitative...
Saved in:
Published in: | American journal of otolaryngology 2007-03, Vol.28 (2), p.73-77 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c473t-a88838442ebf317280d8d5b9821a680066038783c98caa94a36e72879a8e45b33 |
---|---|
cites | cdi_FETCH-LOGICAL-c473t-a88838442ebf317280d8d5b9821a680066038783c98caa94a36e72879a8e45b33 |
container_end_page | 77 |
container_issue | 2 |
container_start_page | 73 |
container_title | American journal of otolaryngology |
container_volume | 28 |
creator | Gisterek, Iwona, MD, PhD Sedlaczek, Paweł, PhD Kornafel, Jan Harłoziñska-Szmyrka, Antonina Łacko, Aleksandra, MD, PhD |
description | Abstract The aim of this study was to assess the impact of radiotherapy on serum vascular endothelial growth factor (VEGF) levels in patients with pharyngeal and laryngeal cancer. Serum VEGF concentrations were determined in 37 patients before, during, and after radiotherapy by using a quantitative sandwich enzyme immunoassay technique. Most (25 patients [68%]) of the studied population were found to have high pretreatment VEGF concentration (of >700 pg/mL; median, 796.3 pg/mL). During radiotherapy, after receiving the total dose of 40 Gy, the median level of serum VEGF remained unchanged (795.2 pg/mL). Regardless of the treatment results, 2 months after completing irradiation the median VEGF level decreased to 448.9 pg/mL, and the difference between pre- and posttreatment medians was statistically significant ( P < .05). No association between pretreatment serum VEGF concentrations and the size of tumor, lymph node status, and patients' age was found. The findings that radiotherapy produces serum VEGF decline in primary pharyngeal and laryngeal carcinomas ( P = .065) may be related to the blocking effect of radiation on local angiogenesis. |
doi_str_mv | 10.1016/j.amjoto.2006.06.015 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70268517</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0196070906001232</els_id><sourcerecordid>70268517</sourcerecordid><originalsourceid>FETCH-LOGICAL-c473t-a88838442ebf317280d8d5b9821a680066038783c98caa94a36e72879a8e45b33</originalsourceid><addsrcrecordid>eNqFkluL1DAUx4Mo7jj6DUQCom8dc-klfRGWxRss-LAKvoUz6elOatt0k3SXefeDm9LBgX0RAiHhd27__yHkNWc7znj5odvB0LnodoKxcrccXjwhG15IkSmufj0lG8brMmMVqy_IixA6xpjMZfGcXPBKlkKxekP-3KCfB3oPwcw9eIpj4-IBews9vfXuIR5oCyY6T-1IJ4gWxxjog03_0wH8cbzFRMLY0P7fK9zNMLg5UIN9Tw14Y0c3AI0eIWKzRnto7FLJw3R8SZ610Ad8dbq35OfnTz-uvmbX3798u7q8zkxeyZiBUkqqPBe4byWv0gCNaop9rQSHUiUVSiZVpaSplQGoc5AlJqqqQWFe7KXckvdr3sm7uxlD1IMNS5MwYupXV0yUqkjibMnbR2DnZj-m3jRnkotc8Gqh8pUy3oXgsdWTt0OSIUF68Uh3evVILx7p5SR7tuTNKfm8H7A5B51MScC7E5Bcgb71MBobzlzNVSVFmbiPK4dJs3uLXgeT_DHYWI8m6sbZ_3XyOIHp7WhTzd94xHCeWQehmb5Z9mlZJ1YyxoUU8i9uUsfC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1031242177</pqid></control><display><type>article</type><title>Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy</title><source>ScienceDirect Journals</source><creator>Gisterek, Iwona, MD, PhD ; Sedlaczek, Paweł, PhD ; Kornafel, Jan ; Harłoziñska-Szmyrka, Antonina ; Łacko, Aleksandra, MD, PhD</creator><creatorcontrib>Gisterek, Iwona, MD, PhD ; Sedlaczek, Paweł, PhD ; Kornafel, Jan ; Harłoziñska-Szmyrka, Antonina ; Łacko, Aleksandra, MD, PhD</creatorcontrib><description>Abstract The aim of this study was to assess the impact of radiotherapy on serum vascular endothelial growth factor (VEGF) levels in patients with pharyngeal and laryngeal cancer. Serum VEGF concentrations were determined in 37 patients before, during, and after radiotherapy by using a quantitative sandwich enzyme immunoassay technique. Most (25 patients [68%]) of the studied population were found to have high pretreatment VEGF concentration (of >700 pg/mL; median, 796.3 pg/mL). During radiotherapy, after receiving the total dose of 40 Gy, the median level of serum VEGF remained unchanged (795.2 pg/mL). Regardless of the treatment results, 2 months after completing irradiation the median VEGF level decreased to 448.9 pg/mL, and the difference between pre- and posttreatment medians was statistically significant ( P < .05). No association between pretreatment serum VEGF concentrations and the size of tumor, lymph node status, and patients' age was found. The findings that radiotherapy produces serum VEGF decline in primary pharyngeal and laryngeal carcinomas ( P = .065) may be related to the blocking effect of radiation on local angiogenesis.</description><identifier>ISSN: 0196-0709</identifier><identifier>EISSN: 1532-818X</identifier><identifier>DOI: 10.1016/j.amjoto.2006.06.015</identifier><identifier>PMID: 17362809</identifier><identifier>CODEN: AJOTDP</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Aged ; Biological and medical sciences ; Carcinoma, Squamous Cell - blood ; Carcinoma, Squamous Cell - mortality ; Carcinoma, Squamous Cell - radiotherapy ; Female ; Humans ; Immunoenzyme Techniques - methods ; Laryngeal Neoplasms - blood ; Laryngeal Neoplasms - mortality ; Laryngeal Neoplasms - radiotherapy ; Male ; Medical sciences ; Middle Aged ; Otolaryngology ; Otorhinolaryngology. Stomatology ; Pharyngeal Neoplasms - blood ; Pharyngeal Neoplasms - mortality ; Pharyngeal Neoplasms - radiotherapy ; Surgery ; Tumors ; Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology ; Vascular Endothelial Growth Factor A - blood</subject><ispartof>American journal of otolaryngology, 2007-03, Vol.28 (2), p.73-77</ispartof><rights>2007</rights><rights>2007 INIST-CNRS</rights><rights>Copyright Elsevier Limited 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c473t-a88838442ebf317280d8d5b9821a680066038783c98caa94a36e72879a8e45b33</citedby><cites>FETCH-LOGICAL-c473t-a88838442ebf317280d8d5b9821a680066038783c98caa94a36e72879a8e45b33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19187326$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17362809$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gisterek, Iwona, MD, PhD</creatorcontrib><creatorcontrib>Sedlaczek, Paweł, PhD</creatorcontrib><creatorcontrib>Kornafel, Jan</creatorcontrib><creatorcontrib>Harłoziñska-Szmyrka, Antonina</creatorcontrib><creatorcontrib>Łacko, Aleksandra, MD, PhD</creatorcontrib><title>Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy</title><title>American journal of otolaryngology</title><addtitle>Am J Otolaryngol</addtitle><description>Abstract The aim of this study was to assess the impact of radiotherapy on serum vascular endothelial growth factor (VEGF) levels in patients with pharyngeal and laryngeal cancer. Serum VEGF concentrations were determined in 37 patients before, during, and after radiotherapy by using a quantitative sandwich enzyme immunoassay technique. Most (25 patients [68%]) of the studied population were found to have high pretreatment VEGF concentration (of >700 pg/mL; median, 796.3 pg/mL). During radiotherapy, after receiving the total dose of 40 Gy, the median level of serum VEGF remained unchanged (795.2 pg/mL). Regardless of the treatment results, 2 months after completing irradiation the median VEGF level decreased to 448.9 pg/mL, and the difference between pre- and posttreatment medians was statistically significant ( P < .05). No association between pretreatment serum VEGF concentrations and the size of tumor, lymph node status, and patients' age was found. The findings that radiotherapy produces serum VEGF decline in primary pharyngeal and laryngeal carcinomas ( P = .065) may be related to the blocking effect of radiation on local angiogenesis.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Squamous Cell - blood</subject><subject>Carcinoma, Squamous Cell - mortality</subject><subject>Carcinoma, Squamous Cell - radiotherapy</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoenzyme Techniques - methods</subject><subject>Laryngeal Neoplasms - blood</subject><subject>Laryngeal Neoplasms - mortality</subject><subject>Laryngeal Neoplasms - radiotherapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Otolaryngology</subject><subject>Otorhinolaryngology. Stomatology</subject><subject>Pharyngeal Neoplasms - blood</subject><subject>Pharyngeal Neoplasms - mortality</subject><subject>Pharyngeal Neoplasms - radiotherapy</subject><subject>Surgery</subject><subject>Tumors</subject><subject>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</subject><subject>Vascular Endothelial Growth Factor A - blood</subject><issn>0196-0709</issn><issn>1532-818X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkluL1DAUx4Mo7jj6DUQCom8dc-klfRGWxRss-LAKvoUz6elOatt0k3SXefeDm9LBgX0RAiHhd27__yHkNWc7znj5odvB0LnodoKxcrccXjwhG15IkSmufj0lG8brMmMVqy_IixA6xpjMZfGcXPBKlkKxekP-3KCfB3oPwcw9eIpj4-IBews9vfXuIR5oCyY6T-1IJ4gWxxjog03_0wH8cbzFRMLY0P7fK9zNMLg5UIN9Tw14Y0c3AI0eIWKzRnto7FLJw3R8SZ610Ad8dbq35OfnTz-uvmbX3798u7q8zkxeyZiBUkqqPBe4byWv0gCNaop9rQSHUiUVSiZVpaSplQGoc5AlJqqqQWFe7KXckvdr3sm7uxlD1IMNS5MwYupXV0yUqkjibMnbR2DnZj-m3jRnkotc8Gqh8pUy3oXgsdWTt0OSIUF68Uh3evVILx7p5SR7tuTNKfm8H7A5B51MScC7E5Bcgb71MBobzlzNVSVFmbiPK4dJs3uLXgeT_DHYWI8m6sbZ_3XyOIHp7WhTzd94xHCeWQehmb5Z9mlZJ1YyxoUU8i9uUsfC</recordid><startdate>20070301</startdate><enddate>20070301</enddate><creator>Gisterek, Iwona, MD, PhD</creator><creator>Sedlaczek, Paweł, PhD</creator><creator>Kornafel, Jan</creator><creator>Harłoziñska-Szmyrka, Antonina</creator><creator>Łacko, Aleksandra, MD, PhD</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope><scope>8BM</scope></search><sort><creationdate>20070301</creationdate><title>Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy</title><author>Gisterek, Iwona, MD, PhD ; Sedlaczek, Paweł, PhD ; Kornafel, Jan ; Harłoziñska-Szmyrka, Antonina ; Łacko, Aleksandra, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c473t-a88838442ebf317280d8d5b9821a680066038783c98caa94a36e72879a8e45b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Squamous Cell - blood</topic><topic>Carcinoma, Squamous Cell - mortality</topic><topic>Carcinoma, Squamous Cell - radiotherapy</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoenzyme Techniques - methods</topic><topic>Laryngeal Neoplasms - blood</topic><topic>Laryngeal Neoplasms - mortality</topic><topic>Laryngeal Neoplasms - radiotherapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Otolaryngology</topic><topic>Otorhinolaryngology. Stomatology</topic><topic>Pharyngeal Neoplasms - blood</topic><topic>Pharyngeal Neoplasms - mortality</topic><topic>Pharyngeal Neoplasms - radiotherapy</topic><topic>Surgery</topic><topic>Tumors</topic><topic>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</topic><topic>Vascular Endothelial Growth Factor A - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gisterek, Iwona, MD, PhD</creatorcontrib><creatorcontrib>Sedlaczek, Paweł, PhD</creatorcontrib><creatorcontrib>Kornafel, Jan</creatorcontrib><creatorcontrib>Harłoziñska-Szmyrka, Antonina</creatorcontrib><creatorcontrib>Łacko, Aleksandra, MD, PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>ComDisDome</collection><jtitle>American journal of otolaryngology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gisterek, Iwona, MD, PhD</au><au>Sedlaczek, Paweł, PhD</au><au>Kornafel, Jan</au><au>Harłoziñska-Szmyrka, Antonina</au><au>Łacko, Aleksandra, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy</atitle><jtitle>American journal of otolaryngology</jtitle><addtitle>Am J Otolaryngol</addtitle><date>2007-03-01</date><risdate>2007</risdate><volume>28</volume><issue>2</issue><spage>73</spage><epage>77</epage><pages>73-77</pages><issn>0196-0709</issn><eissn>1532-818X</eissn><coden>AJOTDP</coden><abstract>Abstract The aim of this study was to assess the impact of radiotherapy on serum vascular endothelial growth factor (VEGF) levels in patients with pharyngeal and laryngeal cancer. Serum VEGF concentrations were determined in 37 patients before, during, and after radiotherapy by using a quantitative sandwich enzyme immunoassay technique. Most (25 patients [68%]) of the studied population were found to have high pretreatment VEGF concentration (of >700 pg/mL; median, 796.3 pg/mL). During radiotherapy, after receiving the total dose of 40 Gy, the median level of serum VEGF remained unchanged (795.2 pg/mL). Regardless of the treatment results, 2 months after completing irradiation the median VEGF level decreased to 448.9 pg/mL, and the difference between pre- and posttreatment medians was statistically significant ( P < .05). No association between pretreatment serum VEGF concentrations and the size of tumor, lymph node status, and patients' age was found. The findings that radiotherapy produces serum VEGF decline in primary pharyngeal and laryngeal carcinomas ( P = .065) may be related to the blocking effect of radiation on local angiogenesis.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>17362809</pmid><doi>10.1016/j.amjoto.2006.06.015</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0196-0709 |
ispartof | American journal of otolaryngology, 2007-03, Vol.28 (2), p.73-77 |
issn | 0196-0709 1532-818X |
language | eng |
recordid | cdi_proquest_miscellaneous_70268517 |
source | ScienceDirect Journals |
subjects | Adult Aged Biological and medical sciences Carcinoma, Squamous Cell - blood Carcinoma, Squamous Cell - mortality Carcinoma, Squamous Cell - radiotherapy Female Humans Immunoenzyme Techniques - methods Laryngeal Neoplasms - blood Laryngeal Neoplasms - mortality Laryngeal Neoplasms - radiotherapy Male Medical sciences Middle Aged Otolaryngology Otorhinolaryngology. Stomatology Pharyngeal Neoplasms - blood Pharyngeal Neoplasms - mortality Pharyngeal Neoplasms - radiotherapy Surgery Tumors Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology Vascular Endothelial Growth Factor A - blood |
title | Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T00%3A35%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20vascular%20endothelial%20growth%20factor%20in%20patients%20with%20pharyngeal%20and%20laryngeal%20squamous%20cell%20carcinoma%20treated%20with%20radiotherapy&rft.jtitle=American%20journal%20of%20otolaryngology&rft.au=Gisterek,%20Iwona,%20MD,%20PhD&rft.date=2007-03-01&rft.volume=28&rft.issue=2&rft.spage=73&rft.epage=77&rft.pages=73-77&rft.issn=0196-0709&rft.eissn=1532-818X&rft.coden=AJOTDP&rft_id=info:doi/10.1016/j.amjoto.2006.06.015&rft_dat=%3Cproquest_cross%3E70268517%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c473t-a88838442ebf317280d8d5b9821a680066038783c98caa94a36e72879a8e45b33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1031242177&rft_id=info:pmid/17362809&rfr_iscdi=true |